The effects of heparin on DLD-1 colon cancer cell line

Bratislava Medical Journal

Volumn 110, Issue 1, 2009, Pages 3-6

  Uzun, Y ^a   Akdogan, E ^a   Ozdemir, F ^a   Ovali, E ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Colon cancer; DLD 1 cell line; Heparin

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLON TUMOR; DRUG EFFECT; HUMAN; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTICOAGULANTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; HEPARIN; HUMANS;

EID: 70349499235     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aruffo A, Bevilacqua MP, Nelson RM, Cecconi O, Roberts WG, Linhardt RJ. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflamation. Blood 1993; 82: 3253-3258.
2. Collen A, Van Noorden CJF, Peters E, Lupu F, Koolwijk P, Smorenburg SM, Van Hinsberg VW. The effects of unfractionated and low molecular weight heparins on micro-vascular endothelial cell proliferation and formation of capillary-like tubular structures in a fibrin matrix. Cancer 2000; 60: 6196-6200.
3. Collen A, Noorden CV, Peters E et al. Unfructionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res 2000; 60: 6196-6200.
4. Letai A, Kuter DJ. Cancer, coagulation, and anticoagulation. Oncologist 1999; 4: 443-449.
5. Obermair A, Bancher-Todesca D, Gitsch G, Bilgi S, Leodolter S. Correlation of vascular endothelial growth factor expression and micro-vessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst 1997; 89: 1212-1217.
6. Ray A, Gouda I, Swedenburg J, Lundmark K et al. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. J Cell Physiol 2002; 193: 35-72.
7. Yýldýran A, Erduran E, Tekelio•lu T, Gedik Y. Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: resuls of a preliminary in vitro study. Amer J Haematol 1999; 61: 90-93.
8. Xiong AH, Li HL, Zhang HW, Ye KH et al. Effects of heparin on apoptosis in human nasopharyngeal carsinoma CNE2 cells. Cell Res 2001; 11: 311-315.
9. Mandal AK, Saklayen MG, Layden TW. Heparin lowers blood pressure: biological and clinical perspectives. Kidney Int 1995; 1017-1022.
10. Fauci AS, Braunwald E et al. Gastrointestinal tract cancer. 571-576. In: Braunwald E, Fauci AS (Eds). Harrison's Principles of Internal Medicine. New York; McGraw-Hill, 1998.
11. Boeryd B, Hagmar B. Disseminating effect of heparin on experi mental tumour metastases. Pat Europ 1969; 4: 274-282.
12. Cosmi B, Piovalla F, Hirsh J, Ginsberg JS, Siragusa S. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Ann J Med 1996; 100: 269-277.
13. Glimelius B, Pohlmen L. Swedish rectal cancer trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. New Engl J Med 1997; 336: 980-987.
14. Gogly B, Pella B, Godeau G, Groult N, Hornebeck W. Influence of heparin(s) on the interleukin-1-beta-induced expression of collagenase, stromely-sin-1, and tissue inhibitor of metalloproteinase-1 inhuman gingival fibroblast. Biochem Pharmacol 1998; 56: 1447-1454.
15. Coller BS, Beutler E et al. Heparin, Hirudin and related agents. 1793-1796. In: Beutler E, Coller BS (Eds). Williams Hematology. New York; The Mc Graw-Hill, 2001.
16. Yamazaki H, Oi H, Tang JT, Matsushita M, Inoue T, Nose T. Heparin induces rapid and remarkable elevation of hepatocyte growth factor/scatter factor during trans arterial embolization in renal cell carcinoma. Anticancer Res 1997; 17: 1435-1437.
17. 2+)/calmodulin-dependent protein kinase II in vascular smooth muscle cells. Amer J Pathol 2002; 11: 1893-1901.
18. Zvibel I, Papa M, Brill S, Fishman S, Halpern Z. Heparin-derived disacchaarides modulate proliferation and erb-b2 mediated signal transduction in colon cancer cell lines. Int J Cancer 2002; 99: 179-184.
19. Talbot IC, Clark ML. Tumours of the gastrointestinal tract. 1990-1993. In: Weatherall DJ, Ledingham GG, Warrell DA (Eds). Williams Heamatology: Oxford textbook of medicine. New York; Oxford Univercity Pres, 1996.
20. Zimmerman J, Bar-Shavit R, Ben-Sasson SA, Peretz T. Control of cell proliferation by heparan sulfate and heparin binding growth factors. Thromb Haemost 1995; 74: 534-540.
21. Grendell JH, McQuaid KR, Bresalier RS, Friedman SL. Malignant and premalignant lesions of the colon. Diagnosis & Treatment in Gastroenterology. Prentice-Hall Int 1996; 367-391.
22. Lo K, Fung LF, Yuen PW, Tsao SW, Wang XH, Liu Y. Differen tial expression in nasopharyngeal carsinoma cells. Life Sci 2000; 67: 923-936.
23. Arenberg DA, Glass M, Burdick MD, Polverini PJ, Streiter RM, Kunkel SL. Inhibition of interleukin-8 reduces tumorogenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792-2802.
24. Levin B, Goldman L et al. Neoplasms of the large and small intes tines. 741-749. In: Thomas EA, Bennett JC (Eds). Cecil Textbook of Medicine. New York; W.B. Saunders Company, 2000
25. Kayaalp SO. Antikoagiilan ila•lar. 586-591. Tibbi farmakoloji. Ankara; Hacettepe-Tas Kitapcilik Ltd. Sti, 2002.